vs
Assertio Holdings, Inc.(ASRT)与REDWOOD TRUST INC(RWT)财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是Assertio Holdings, Inc.的1.9倍($25.9M vs $13.5M),REDWOOD TRUST INC同比增速更快(-6.1% vs -57.9%),过去两年Assertio Holdings, Inc.的营收复合增速更高(-35.4% vs -41.0%)
Assertio Therapeutics是一家美国专业制药企业,主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年,总部位于加利福尼亚州纽瓦克,拥有多款获美国FDA批准的产品,目前在纳斯达克上市。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司,主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理,核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务,客户以机构投资者和房地产市场参与者为主。
ASRT vs RWT — 直观对比
营收规模更大
RWT
是对方的1.9倍
$13.5M
营收增速更快
RWT
高出51.8%
-57.9%
两年增速更快
ASRT
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.5M | $25.9M |
| 净利润 | — | $20.0M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | — |
| 净利率 | — | 77.2% |
| 营收同比 | -57.9% | -6.1% |
| 净利润同比 | — | 402.6% |
| 每股收益(稀释后) | $-4.54 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASRT
RWT
| Q4 25 | $13.5M | $25.9M | ||
| Q3 25 | $49.5M | $15.0M | ||
| Q2 25 | $29.2M | $13.8M | ||
| Q1 25 | $26.5M | $27.9M | ||
| Q4 24 | $32.2M | $27.6M | ||
| Q3 24 | $29.2M | $25.5M | ||
| Q2 24 | $31.1M | $67.4M | ||
| Q1 24 | $32.4M | $74.5M |
净利润
ASRT
RWT
| Q4 25 | — | $20.0M | ||
| Q3 25 | $11.4M | $-7.7M | ||
| Q2 25 | $-16.4M | $-98.5M | ||
| Q1 25 | $-13.5M | $16.1M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-2.9M | $14.8M | ||
| Q2 24 | $-3.7M | $15.5M | ||
| Q1 24 | $-4.5M | $30.3M |
营业利润率
ASRT
RWT
| Q4 25 | -86.7% | — | ||
| Q3 25 | 23.2% | -9.0% | ||
| Q2 25 | -27.5% | -679.0% | ||
| Q1 25 | -50.0% | 80.2% | ||
| Q4 24 | -41.9% | -1.3% | ||
| Q3 24 | -10.4% | 86.1% | ||
| Q2 24 | -11.6% | 30.3% | ||
| Q1 24 | -13.4% | 41.3% |
净利率
ASRT
RWT
| Q4 25 | — | 77.2% | ||
| Q3 25 | 23.1% | -51.4% | ||
| Q2 25 | -56.0% | -712.0% | ||
| Q1 25 | -51.1% | 57.8% | ||
| Q4 24 | — | -24.0% | ||
| Q3 24 | -10.0% | 58.1% | ||
| Q2 24 | -11.8% | 23.0% | ||
| Q1 24 | -13.9% | 40.6% |
每股收益(稀释后)
ASRT
RWT
| Q4 25 | $-4.54 | $0.11 | ||
| Q3 25 | $0.11 | $-0.08 | ||
| Q2 25 | $-0.17 | $-0.76 | ||
| Q1 25 | $-0.14 | $0.10 | ||
| Q4 24 | $-3.28 | $-0.08 | ||
| Q3 24 | $-0.03 | $0.09 | ||
| Q2 24 | $-0.04 | $0.10 | ||
| Q1 24 | $-0.05 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $982.6M |
| 总资产 | $267.0M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASRT
RWT
| Q4 25 | $63.4M | $255.7M | ||
| Q3 25 | $93.4M | $226.3M | ||
| Q2 25 | $98.2M | $302.0M | ||
| Q1 25 | $87.3M | $259.9M | ||
| Q4 24 | $100.1M | $245.2M | ||
| Q3 24 | $88.6M | $253.7M | ||
| Q2 24 | $88.4M | $275.6M | ||
| Q1 24 | $80.7M | $275.4M |
总债务
ASRT
RWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | $1.7B |
股东权益
ASRT
RWT
| Q4 25 | $94.0M | $982.6M | ||
| Q3 25 | $105.8M | $999.0M | ||
| Q2 25 | $93.3M | $1.1B | ||
| Q1 25 | $108.5M | $1.2B | ||
| Q4 24 | $121.1M | $1.2B | ||
| Q3 24 | $130.5M | $1.2B | ||
| Q2 24 | $132.2M | $1.2B | ||
| Q1 24 | $134.5M | $1.2B |
总资产
ASRT
RWT
| Q4 25 | $267.0M | $23.7B | ||
| Q3 25 | $319.8M | $22.6B | ||
| Q2 25 | $273.8M | $21.3B | ||
| Q1 25 | $286.4M | $19.9B | ||
| Q4 24 | $284.7M | $18.3B | ||
| Q3 24 | $276.0M | $18.4B | ||
| Q2 24 | $279.4M | $16.5B | ||
| Q1 24 | $282.0M | $15.1B |
负债/权益比
ASRT
RWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ASRT
RWT
| Q4 25 | $-30.0M | $-10.1B | ||
| Q3 25 | $-4.8M | $-2.7B | ||
| Q2 25 | $19.1M | $-2.1B | ||
| Q1 25 | $-12.5M | $-2.0B | ||
| Q4 24 | $11.5M | $-5.9B | ||
| Q3 24 | $-35.0K | $-2.1B | ||
| Q2 24 | $7.4M | $-2.0B | ||
| Q1 24 | $7.5M | $-954.2M |
资本支出强度
ASRT
RWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
ASRT
RWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
RWT
暂无分部数据